Effects of different levels of TGF-β expression and tumor cell necrosis rates in osteosarcoma on the chemotherapy resistance of osteosarcoma

Effects of different levels of TGF-β expression and tumor cell necrosis rates in osteosarcoma on the chemotherapy resistance of osteosarcoma

Purpose: The clinical significance of transforming growth factor β (TGF-β) and tumor cell necrosis rate (TCNR) in the expression of osteosarcoma and its effects of chemotherapy resistance on osteosarcoma were explored. Patients and methods: 94 cases of neoadjuvant chemotherapy osteosarcoma patients...

Full description

Bibliographic Details
Main Authors:	Ling Zhou, Jiadai Tang, Fengdi Hu, Yedan Liao, Rong Li, Yonghong Zhou, Zhihong Yao, Zhengqin Geng, Zuozhang Yang, Xueqi Zhang, Lin Xie
Format:	Article
Language:	English
Published:	Elsevier 2020-08-01
Series:	Journal of Bone Oncology
Subjects:	TGF-β Tumor cell necrosis rate Osteosarcoma Chemotherapy resistance
Online Access:	http://www.sciencedirect.com/science/article/pii/S2212137420300543

Similar Items

Alterations in Tgf-β Signaling Mediate the Biologic Behaviour of Osteosarcoma Cell Lines
by: Deheshi, Benjamin Michael
Published: (2010)

Alterations in Tgf-β Signaling Mediate the Biologic Behaviour of Osteosarcoma Cell Lines
by: Deheshi, Benjamin Michael
Published: (2010)

Assessing the Percent of Necrosis after Neoadjuvant Chemotherapy with 24hr Infusional Cisplatin/3 Days Doxorubicin Intermittent with IfosfamideDoxorubicin for Osteosarcoma
by: Mozhgan Aalam Samimi, et al.
Published: (2014-03-01)

Development of a Nomogram for Predicting the Efficacy of Preoperative Chemotherapy in Osteosarcoma
by: Huang Q, et al.
Published: (2021-08-01)

TGF-β Signaling in Bone Remodeling and Osteosarcoma Progression
by: Audrey Lamora, et al.
Published: (2016-11-01)

The Plasma Concentration of D-Dimer is Associated with Neoadjuvant-Chemotherapy Efficacy and the Prognosis in Osteosarcoma
by: Huang Y, et al.
Published: (2021-01-01)

Adoptive Natural Killer Cell Immunotherapy for Canine Osteosarcoma
by: William C. Kisseberth, et al.
Published: (2021-06-01)

TGF-β downregulates CAIII expression via MAPK and PI3K signaling pathways in colon carcinoma and osteosarcoma cells
by: Aydogan Turkoglu Sumeyye, et al.
Published: (2019-01-01)

Suboptimal chemotherapy is an adverse prognostic factor in osteosarcoma
by: Yong Bicheng, et al.
Published: (2012-09-01)

Chemotherapy in the management of periosteal osteosarcoma: A narrative review
by: Tarek Assi, et al.
Published: (2021-10-01)

Neoadjuvant and Adjuvant Chemotherapy in Osteosarcoma (The Experience of HORC in the Shariati Hospital)
by: K Alimoghadam, et al.
Published: (2004-03-01)

TGF-β1 Promotes Osteosarcoma Cell Migration and Invasion Through the miR-143-Versican Pathway
by: Fengfeng Li, et al.
Published: (2014-12-01)

Advances in limb salvage treatment of osteosarcoma
by: Yichun Yang, et al.
Published: (2018-03-01)

An evaluation of TAZ and YAP crosstalk with TGFβ signalling in canine osteosarcoma suggests involvement of hippo signalling in disease progression
by: Anita K. Luu, et al.
Published: (2018-11-01)

The role of diffusion-weighted MRI in assessment of response to chemotherapy in osteosarcoma
by: Tarek Ahmed Raafat, et al.
Published: (2021-01-01)

Mechanisms of Resistance to Conventional Therapies for Osteosarcoma
by: Louise Marchandet, et al.
Published: (2021-02-01)

Evaluation of the Osteosarcoma Chemotherapy Regimens and its Treatment Results in Meshed Omid Hospital
by: Roham Salek, et al.
Published: (2004-12-01)

Osteosarcoma – on the way to personalized therapy. Part I: standard chemotherapy in the present
by: M. Yu. Rykov, et al.
Published: (2019-05-01)

Surface osteosarcoma: Clinical features and therapeutic implications
by: H. Nouri, et al.
Published: (2015-12-01)

Hsa_circ_0051079 functions as an oncogene by regulating miR-26a-5p/TGF-β1 in osteosarcoma
by: Zuojun Zhang, et al.
Published: (2019-11-01)

Feasibility of multi-parametric magnetic resonance imaging combined with machine learning in the assessment of necrosis of osteosarcoma after neoadjuvant chemotherapy: a preliminary study
by: Bingsheng Huang, et al.
Published: (2020-04-01)

The Clinical Significance of miR-21 in Guiding Chemotherapy for Patients with Osteosarcoma
by: Li LZ, et al.
Published: (2021-09-01)

Osteosarcoma with atypical location in an elderly female patient
by: Daniel Cury Ogata, et al.
Published: (2011-12-01)

Significance of circulating tumor cells in osteosarcoma patients treated by neoadjuvant chemotherapy and surgery
by: Wu ZJ, et al.
Published: (2018-09-01)

Reviews on TCM in Reversing Chemotherapy Resistance of Osteosarcoma from ABC Transmembrane Protein
by: DING Juxian, et al.
Published: (2021-03-01)

Guideline for Limb‐Salvage Treatment of Osteosarcoma
by: Ming Xu, et al.
Published: (2020-08-01)

Immunohistochemical expression of β-catenin in osteoblastoma and osteosarcoma
by: Noha E.D Hassab El-Naby, et al.
Published: (2016-01-01)

Right ventricular 2D speckle-tracking echocardiography in children with osteosarcoma under chemotherapy
by: Ibtsam Khairat, et al.
Published: (2019-11-01)

The significance of MGMT protein detection in evaluation of osteosarcoma necrosis rate after cisplatin chemotherapy
by: Qiu Cui, et al.
Published: (2011-05-01)

Conventional osteosarcoma of the mandible successfully treated with radical surgery and adjuvant chemotherapy after responding poorly to neoadjuvant chemotherapy: a case report
by: Yutaro Kimura, et al.
Published: (2017-08-01)

Is There a Reliable Method to Predict the Limb Length Discrepancy after Chemotherapy and Limb Salvage Surgery in Children with Osteosarcoma?
by: Yuan Li, et al.
Published: (2016-01-01)

Reconstruction using a frozen autograft for a skull and humeral lesion of synchronous multicentric osteosarcoma after undergoing successful neoadjuvant chemotherapy: a case report and review of the literature
by: Yoshihiro Araki, et al.
Published: (2021-01-01)

Histological assessment of the effect of neoadjuvant chemotherapy on conventional high grade osteosarcoma of the long bones
by: JB Thapa
Published: (2011-03-01)

Identification of Prognostic and Predictive Osteosarcoma Biomarkers
by: Radoslav Zamborsky, et al.
Published: (2019-02-01)

Association Between Osteogenic Differentiation in Soft Tissue Lump and Clinicopathological Characteristics of Osteosarcoma Patients
by: WU Zhaoyang, et al.
Published: (2021-09-01)

Neoadjuvant chemotherapy combined with limb salvage surgery in patients with limb osteosarcoma of Enneking stage II: a retrospective study
by: Yuan G, et al.
Published: (2017-05-01)

Gemcitabine in Combination with Carboplatin Exhibits Biologic Activity Against Canine Osteosarcoma
by: McMahon, Melanie B.
Published: (2009)

Reduced cell proliferation and promotion of apoptosis by Leu5AMD in osteosarcoma cells
by: Wu Xiaofeng, et al.
Published: (2017-01-01)

Case Report: Sequential Chemotherapy and Immunotherapy Produce Sustained Response in Osteosarcoma With High Tumor Mutational Burden
by: Shuier Zheng, et al.
Published: (2021-06-01)

Systematic Review of Recurrent Osteosarcoma Systemic Therapy
by: Ioanna Gazouli, et al.
Published: (2021-04-01)